Potent VEGFR-2 inhibitors for resistant breast cancer: a comprehensive 3D-QSAR, ADMET, molecular docking and MMPBSA calculation on triazolopyrazine derivatives.

导出 LinkOut

翻译打印收藏纠错

作者： Soukayna,Baammi ^[1] ; Achraf,El Allali ^[2] ; Rachid,Daoud ^[2]

作者单位： Chemical and Biochemical Sciences-Green Processing Engineering, Mohammed VI Polytechnic University, Ben Guerir, Morocco. ^[1] Bioinformatics Laboratory, College of Computing, Mohammed VI Polytechnic University, Ben Guerir, Morocco. ^[2]

关键词 3D-QSAR ADMET MMPBSA calculation VEGFR-2 breast cancer molecular docking molecular dynamic simulations triazolopyrazine

DOI 10.3389/fmolb.2023.1288652

PMID 38074087

发布时间 2023-12-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in molecular biosciences

2023年10卷

1288652页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Potent VEGFR-2 inhibitors for resistant breast cancer: a comprehensive 3D-QSAR, ADMET, molecular docking and MMPBSA calculation on triazolopyrazine derivatives.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Potent VEGFR-2 inhibitors for resistant breast cancer: a comprehensive 3D-QSAR, ADMET, molecular docking and MMPBSA calculation on triazolopyrazine derivatives.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

检索历史清除